Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet Therapy in HIV
NCT02559414Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, clopidogrel in cardiovascular disease (CVD), inflammation, sponsored by NYU Langone Health. Started Feb 2015; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
cardiovascular disease (CVD)inflammation
Beyond the preview
Go deeper on NCT02559414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559414.